Christina Pentafragka, Ph.D.

Director, Quality Control & Medical Writing Consultant

Portrait-of-Christina-Pentafragka_Pharmetheus

Bio

  • Joined Pharmetheus in 2023, actively working in client projects, with continuous improvements, and providing medical writing support
  • Expertise includes medical writing and quality control across therapeutic areas
  • Previously worked as Senior Clinical Research Officer at Elpen Pharmaceutical, Greece, and as a post-graduate in the DMPK and Pharmacometrics groups at Novartis, Switzerland
  • M.Sc. in Pharmacokinetics (2015) from Aix-Marseille University in Marseille, France, and Ph.D. in Biopharmaceutics (2020) from the National and Kapodistrian University of Athens, Greece
LinkedInGoogle Scholar

Pharmetheus affiliated publications

Exposure-Overall Survival Analysis for Quizartinib in Newly Diagnosed Patients with FMS- Like Tyrosine Kinase 3-Internal-Tandem-Duplication-Positive Acute Myeloid LeukemiaPopulation Pharmacokinetic Analysis of Datopotamab Deruxtecan (Dato-DXd), a TROP2-Directed Antibody-Drug Conjugate, in Patients With Advanced Solid TumorsPopulation pharmacokinetic analysis of quizartinib in patients with newly diagnosed FLT3-internal-tandem-duplication-positive acute myeloid leukemiaConcentration-QTcF analysis of quizartinib in patients with newly diagnosed FLT3-internal-tandem-duplication-positive acute myeloid leukemia